Detalhe da pesquisa
1.
[Combination of Jianpi Liqi Yiliu Formula with Cytokine-induced Killer Cell Treatment for Advanced Hepatocellular Carcinoma].
Zhongguo Zhong Xi Yi Jie He Za Zhi
; 36(2): 160-5, 2016 Feb.
Artigo
em Zh
| MEDLINE | ID: mdl-27078990
2.
[Treating primary liver cancer patients by Pi-strengthening and Qi-regulating method: univariate and multivariate analyses of their prognoses].
Zhongguo Zhong Xi Yi Jie He Za Zhi
; 34(2): 162-6, 2014 Feb.
Artigo
em Zh
| MEDLINE | ID: mdl-24672939
3.
[The distribution of Chinese medicine syndrome types in primary liver cancer and their differences of the survival time: a clinical study].
Zhongguo Zhong Xi Yi Jie He Za Zhi
; 33(7): 911-4, 2013 Jul.
Artigo
em Zh
| MEDLINE | ID: mdl-24063211
4.
Gefitinib plus Fuzheng Kang'ai Formula () in Patients with Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation: A Randomized Controlled Trial.
Chin J Integr Med
; 24(10): 734-740, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28795387
5.
[Study on changes of TCM syndrome in patients with coronary heart disease before and after intervention treatment].
Zhongguo Zhong Xi Yi Jie He Za Zhi
; 27(8): 689-91, 2007 Aug.
Artigo
em Zh
| MEDLINE | ID: mdl-17879529
6.
Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial.
Trials
; 16: 146, 2015 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25873045
7.
Effect of gefitinib plus Chinese herbal medicine (CHM) in patients with advanced non-small-cell lung cancer: a retrospective case-control study.
Complement Ther Med
; 22(6): 1010-8, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25453521